Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-016013
Filing Date
2025-09-29
Accepted
2025-09-29 16:30:36
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 390681
2 EX-5.1 ex5-1.htm EX-5.1 23810
3 EX-23.1 ex23-1.htm EX-23.1 3565
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 31650
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3070
6 GRAPHIC forms-3_001.jpg GRAPHIC 4601
  Complete submission text file 0001493152-25-016013.txt   585248

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5723
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290580 | Film No.: 251356531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)